SCHEMBL856773

SCHEMBL856773

Cc1ccc2ncnc(N3CCOc4ccc(-c5cnc6c(c5)nc(OC(N)=O)n6Cc5ccccc5)cc4C3)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 3/20 0.40
PDGFRB P09619 1/20 0.36
AKT1 P31749 2/20 0.35
MTOR P42345 1/20 0.35
CLK4 Q9HAZ1 6/20 0.35
ALDH1A1 P00352 5/20 0.35
MAPK1 P28482 5/20 0.35
CYP2C19 P33261 5/20 0.35
TSHR P16473 4/20 0.35
HIF1A Q16665 4/20 0.35
CYP1A2 P05177 5/20 0.34
CYP3A4 P08684 5/20 0.34
LMNA P02545 4/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TP53 P04637 1/20 0.34
BRD4 O60885 1/20 0.34
CYP2D6 P10635 4/20 0.34
USP2 O75604 2/20 0.34
PDE10A Q9Y233 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL856772 0.77 PIK3CA (0.38) PIK3CAPDGFRBMTORCLK4ALDH1A1
SCHEMBL3757572 0.76 PIK3CA (0.39) PIK3CAPDGFRBAKT1MTORCLK4
SCHEMBL6126231 0.76 CYP3A4 (0.43) PIK3CACLK4ALDH1A1MAPK1CYP2C19
SCHEMBL856771 0.76 CREBBP (0.37) PIK3CAPDGFRBAKT1CLK4ALDH1A1
SCHEMBL6126132 0.75 PIK3CA (0.40) PIK3CAPDGFRBMTORCLK4ALDH1A1
SCHEMBL856147 0.73 CYP3A4 (0.41) PIK3CACLK4ALDH1A1MAPK1CYP2C19
SCHEMBL858661 0.71 LMNA (0.41) PIK3CACLK4ALDH1A1MAPK1CYP2C19
SCHEMBL3719872 0.71 CYP3A4 (0.42) CLK4ALDH1A1MAPK1CYP2C19TSHR
SCHEMBL3763910 0.70 PRMT5 (0.45) PIK3CACLK4ALDH1A1MAPK1CYP2C19
SCHEMBL857187 0.69 PIK3CA (0.51) PIK3CACLK4ALDH1A1MAPK1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432779-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES Exelixis, Inc. (US) 2012-03-28 EP disclosed